Multicenter trial explores additional effects of indomethacin to prevent IVH in infants with steroid exposure, suggesting enhanced protective strategies.
Following the publication of our multicenter randomized indomethacin intraventricular hemorrhage (IVH) prevention trial in Pediatrics,1 we received numerous queries concerning our protocol outcome variables. None was more intriguing to us, however, than the question of David Braun, MD, who asked what additional protective effect might be offered by the early administration of indomethacin to those infants who had been exposed to antenatal steroid administration and had no evidence of IVH at 6 hours postnatal age.
No takes yet. Share an insight, caveat, or question.
Ment et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: